IT´S OVER, COVIDFAGS BLOWN THE FUCK OUT
No.13757672 ViewReplyOriginalReport
Quoted By: >>13757674 >>13757757 >>13757941 >>13758097
molnupiravir may end Covid-19
https://www.bloomberg.com/news/articles/2021-10-11/merck-seeks-emergency-use-authorization-for-pill-to-treat-covid
https://pubmed.ncbi.nlm.nih.gov/34159342/
>Conclusions: Molnupiravir is the first oral, direct-acting antiviral shown to be highly effective at reducing nasopharyngeal SARS-CoV-2 infectious virus and viral RNA and has a favorable safety and tolerability profile.
>Results: Among 202 treated participants, virus isolation was significantly lower in participants receiving 800 mg molnupiravir (1.9%) versus placebo (16.7%) at Day 3 (p = 0.02). At Day 5, virus was not isolated from any participants receiving 400 or 800 mg molnupiravir, versus 11.1% of those receiving placebo (p = 0.03)
https://www.bloomberg.com/news/articles/2021-10-11/merck-seeks-emergency-use-authorization-for-pill-to-treat-covid
https://pubmed.ncbi.nlm.nih.gov/34159342/
>Conclusions: Molnupiravir is the first oral, direct-acting antiviral shown to be highly effective at reducing nasopharyngeal SARS-CoV-2 infectious virus and viral RNA and has a favorable safety and tolerability profile.
>Results: Among 202 treated participants, virus isolation was significantly lower in participants receiving 800 mg molnupiravir (1.9%) versus placebo (16.7%) at Day 3 (p = 0.02). At Day 5, virus was not isolated from any participants receiving 400 or 800 mg molnupiravir, versus 11.1% of those receiving placebo (p = 0.03)
